247 related articles for article (PubMed ID: 11245034)
21. [Treatment of malignant gliomas by selective intraarterial infusion chemotherapy with high-dose ACNU and autologous bone marrow transplantation--preliminary report].
Nakagawa H; Murasawa A; Taki T; Nakajima S; Niiyama K; Furuta Y; Fujita T; Tsuruzono K; Nakamura H; Shibata H
Gan To Kagaku Ryoho; 1991 Nov; 18(14):2435-40. PubMed ID: 1659327
[TBL] [Abstract][Full Text] [Related]
22. [Therapeutic effect on glioblastoma of chemotherapy on the basis of brain irradiation].
Qin D; Mo H; Ou G
Zhonghua Zhong Liu Za Zhi; 2001 Mar; 23(2):168-9. PubMed ID: 11783028
[TBL] [Abstract][Full Text] [Related]
23. Reduced systemic drug exposure by combining intraarterial cis-diamminedichloroplatinum(II) with hemodialysis of regional venous drainage.
Oldfield EH; Clark WC; Dedrick RL; Egorin MJ; Austin HA; DeVroom HD; Joyce KM; Doppman JL
Cancer Res; 1987 Apr; 47(7):1962-7. PubMed ID: 3815385
[TBL] [Abstract][Full Text] [Related]
24. The modulation of protein kinase A and heat shock protein 70 is involved in the reversible increase of blood-brain tumor barrier permeability induced by papaverine.
Wang ZH; Xue YX; Liu YH
Brain Res Bull; 2010 Nov; 83(6):367-73. PubMed ID: 20728510
[TBL] [Abstract][Full Text] [Related]
25. Bradykinin selectively opens blood-tumor barrier in experimental brain tumors.
Inamura T; Black KL
J Cereb Blood Flow Metab; 1994 Sep; 14(5):862-70. PubMed ID: 8063881
[TBL] [Abstract][Full Text] [Related]
26. Graded reversible opening of the rat blood-brain barrier by intracarotid infusion of sodium caprate.
Preston E; Slinn J; Vinokourov I; Stanimirovic D
J Neurosci Methods; 2008 Mar; 168(2):443-9. PubMed ID: 18155299
[TBL] [Abstract][Full Text] [Related]
27. Osmotic blood-brain barrier disruption: pharmacodynamic studies in dogs and a clinical phase I trial in patients with malignant brain tumors.
Neuwelt EA; Hill SA; Frenkel EP; Diehl JT; Maravilla KR; Vu LH; Clark WK; Rapoport SI; Barnett PA; Lewis SE; Ehle AL; Beyer CW
Cancer Treat Rep; 1981; 65 Suppl 2():39-43. PubMed ID: 6809316
[TBL] [Abstract][Full Text] [Related]
28. [Chemotherapy of malignant brain tumors by intermittent and continuous intra-arterial infusion of antitumor agents--clinical study].
Sato O
No To Shinkei; 1966 Nov; 18(11):1103-21. PubMed ID: 4292939
[No Abstract] [Full Text] [Related]
29. [Pharmacokinetics of plasma and cerebrospinal fluid cisplatin in patients with malignant glioma and metastatic brain tumor after selective intraarterial or intravenous and intracarotid administration of etoposide and cisplatin].
Nakagawa H; Miyawaki Y; Tokiyoshi K; Tsuruzono K; Yamada M; Kanayama T; Hayakawa T
No Shinkei Geka; 1994 Jan; 22(1):35-42. PubMed ID: 8295700
[TBL] [Abstract][Full Text] [Related]
30. Hypericin uptake: a prognostic marker for survival in high-grade glioma.
Ritz R; Müller M; Dietz K; Duffner F; Bornemann A; Roser F; Tatagiba M
J Clin Neurosci; 2008 Jul; 15(7):778-83. PubMed ID: 18394904
[TBL] [Abstract][Full Text] [Related]
31. Radiotherapy plus concurrent and adjuvant procarbazine, lomustine, and vincristine chemotherapy for patients with malignant glioma.
Yang SH; Hong YK; Yoon SC; Kim BS; Lee YS; Lee TK; Lee KS; Jeun SS; Kim MC; Park CK
Oncol Rep; 2007 Jun; 17(6):1359-64. PubMed ID: 17487391
[TBL] [Abstract][Full Text] [Related]
32. Dose escalation of carmustine in surgically implanted polymers in patients with recurrent malignant glioma: a New Approaches to Brain Tumor Therapy CNS Consortium trial.
Olivi A; Grossman SA; Tatter S; Barker F; Judy K; Olsen J; Bruce J; Hilt D; Fisher J; Piantadosi S;
J Clin Oncol; 2003 May; 21(9):1845-9. PubMed ID: 12721262
[TBL] [Abstract][Full Text] [Related]
33. [Prognostic analysis of patients with cerebral glioma treated with radiotherapy].
Wu SX; Deng ML; Li QQ; Zhao C; Lu TX; Li FY; Cui NJ
Ai Zheng; 2004 Nov; 23(11 Suppl):1561-6. PubMed ID: 15566680
[TBL] [Abstract][Full Text] [Related]
34. Methotrexate loaded polyether-copolyester dendrimers for the treatment of gliomas: enhanced efficacy and intratumoral transport capability.
Dhanikula RS; Argaw A; Bouchard JF; Hildgen P
Mol Pharm; 2008; 5(1):105-16. PubMed ID: 18171013
[TBL] [Abstract][Full Text] [Related]
35. Phase I/II clinical trial of carbon ion radiotherapy for malignant gliomas: combined X-ray radiotherapy, chemotherapy, and carbon ion radiotherapy.
Mizoe JE; Tsujii H; Hasegawa A; Yanagi T; Takagi R; Kamada T; Tsuji H; Takakura K;
Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):390-6. PubMed ID: 17459607
[TBL] [Abstract][Full Text] [Related]
36. Supraophthalmic carotid infusion for recurrent glioma: rationale, technique, and preliminary results for cisplatin and BCNU.
Kapp JP; Vance RB
J Neurooncol; 1985; 3(1):5-11. PubMed ID: 2987427
[TBL] [Abstract][Full Text] [Related]
37. [Clinical significance of mustoforan in management of malignant glioma].
Kobiakov GL
Vopr Onkol; 2007; 53(6):724-9. PubMed ID: 18416147
[No Abstract] [Full Text] [Related]
38. Quantitative analysis of papaverine-mediated blood-brain barrier disruption in rats.
Bhattacharjee AK; Kondoh T; Nagashima T; Ikeda M; Ehara K; Tamaki N
Biochem Biophys Res Commun; 2001 Nov; 289(2):548-52. PubMed ID: 11716508
[TBL] [Abstract][Full Text] [Related]
39. [Intratumoral pharmacokinetics following intraarterial administration of MCNU in patients with malignant gliomas].
Yamasaki T; Nagao S; Kagawa T; Konishi S; Akiyama Y; Fukuda M; Kimura Y; Moritake K
No Shinkei Geka; 1995 Nov; 23(11):963-9. PubMed ID: 7477717
[TBL] [Abstract][Full Text] [Related]
40. Use of Gliadel (BCNU) wafer in the surgical treatment of malignant glioma: a 10-year institutional experience.
Attenello FJ; Mukherjee D; Datoo G; McGirt MJ; Bohan E; Weingart JD; Olivi A; Quinones-Hinojosa A; Brem H
Ann Surg Oncol; 2008 Oct; 15(10):2887-93. PubMed ID: 18636295
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
